Lyophilization Services of New England

We are a global, integrated CDMO, your bridge between life-changing therapies and patients. We are driving development, connecting commercialization, and truly spanning the cycle. Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close. Our people’s priority and focus are on providing an industry-leading customer experience. In addition, we will enhance our offering through strategic acquisitions and partnerships, and in doing so, we will meet the needs of our clients globally. By differentiating ourselves with investment in technology and talent, we will always provide a transformational customer experience and exceed expectations. As a respected industry leader, we provide a comprehensive range of pharmaceutical services from the earliest stages of development through to commercial launch and beyond. Accelerating your drug product through development to commercialization and beyond.